Journal of travel medicine
Subcutaneous ivermectin treatment in severe strongyloidiasis: is it time to recommend drug concentration measurements and parasitological stool monitoring follow-up?
Andrea Allgöwer, Anne Lespine, Caroline Bastid, Sigiriya Aebischer Perone, Gabriel Alcoba, Jean-François Sutra, Anne Mauris, Laurent Getaz, François Chappuis, Gilles Eperon
Published: 202510.1093/jtm/taaf122
Abstract
Strongyloides stercoralis can cause life-threatening infections. Subcutaneous veterinary formulations of ivermectin (IVM) may be the only option for severe treatment, but the dosage and duration are empirical. This article, based on a clinical case,…
Preview only. Read the full abstract at the source